Jonathan Brüün to leave CEO role at the British Pharmacological Society
Brüün has announced he will be leaving his role as CEO at the BPS and moving to a new role at the Royal College of Anaesthetists.
Jonathan Brüün (credit: British Pharmacological Society, www.bps.ac.uk).
Jonathan Brüün has announced he will be leaving his role as CEO of the British Pharmacological Society (BPS) in January 2020. He will be taking up a new post as Chief Executive of the Royal College of Anaesthetists.
Brüün became CEO of the British Pharmacological Society in June 2012. He has had overall responsibility for strategic and financial management, business development, human resources, policy development, governance and the oversight of projects that are designed to support the UK and international pharmacology community.
During Brüün’s time as CEO, the British Pharmacological Society membership rose by over 20 percent. He also expanded the staff team in this same period to ensure effective delivery of the Society’s core objectives – the promotion of the discipline of pharmacology, clinical pharmacology and therapeutics.
“I’m very proud of everything we have achieved together, whether it’s the growth in member numbers and satisfaction, the establishment of a policy unit which truly punches above its weight, the focus on quality in our annual meetings and the development of a content strategy led by a scientific advisory panel to help deliver this, the continued professionalisation of the BPS office and the generation of new sources of revenue to underpin our future activities. All this will ensure BPS will be a happy and inclusive home for anyone with an interest in pharmacology, clinical pharmacology and therapeutics in future,” said Brüün.
The Trustees of the Society will meet 22 August 2019 to plan the recruitment process for a new CEO, which is expected to begin imminently.